Avantor, Inc. (NYSE:AVTR) Stock Holdings Cut by abrdn plc

abrdn plc decreased its stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 31.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 694,309 shares of the company's stock after selling 321,725 shares during the period. abrdn plc owned 0.10% of Avantor worth $17,962,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of AVTR. Versant Capital Management Inc increased its holdings in shares of Avantor by 2,003.6% during the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company's stock worth $25,000 after buying an additional 1,102 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of Avantor by 1,830.3% during the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company's stock worth $31,000 after purchasing an additional 1,391 shares during the period. UMB Bank n.a. purchased a new stake in shares of Avantor during the 3rd quarter worth about $49,000. Nisa Investment Advisors LLC increased its position in Avantor by 69.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company's stock worth $53,000 after purchasing an additional 835 shares in the last quarter. Finally, GAMMA Investing LLC raised its holdings in Avantor by 89.9% in the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company's stock valued at $70,000 after buying an additional 1,285 shares during the period. Hedge funds and other institutional investors own 95.08% of the company's stock.

Insider Transactions at Avantor

In other news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the transaction, the chief accounting officer now directly owns 29,544 shares of the company's stock, valued at approximately $740,372.64. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 1.50% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on AVTR shares. Morgan Stanley increased their price objective on shares of Avantor from $28.00 to $29.00 and gave the stock an "overweight" rating in a research report on Monday, July 29th. TD Cowen increased their price target on Avantor from $28.00 to $31.00 and gave the company a "buy" rating in a report on Monday, July 29th. Citigroup lowered Avantor from a "buy" rating to a "neutral" rating and cut their price objective for the company from $30.00 to $23.00 in a research report on Wednesday, July 10th. Stifel Nicolaus upped their target price on Avantor from $27.00 to $28.00 and gave the stock a "buy" rating in a research report on Monday, July 29th. Finally, Barclays lowered their price objective on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating for the company in a research report on Friday, October 25th. Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. Based on data from MarketBeat, Avantor currently has a consensus rating of "Moderate Buy" and a consensus price target of $27.57.

Avantor Stock Down 0.2 %

Shares of AVTR stock traded down $0.04 during trading hours on Friday, hitting $22.33. 6,445,666 shares of the company were exchanged, compared to its average volume of 6,441,791. The stock has a market capitalization of $15.20 billion, a price-to-earnings ratio of 48.54, a P/E/G ratio of 2.71 and a beta of 1.33. Avantor, Inc. has a one year low of $17.46 and a one year high of $28.00. The business's 50-day simple moving average is $25.20 and its two-hundred day simple moving average is $24.18. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.05 and a current ratio of 1.54.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.